Full-Time

Quality Assurance Manager

Granules

Granules

501-1,000 employees

Vertically integrated API and dosage manufacturer

Compensation Overview

$115k/yr

Chantilly, VA, USA

In Person

Bachelor's, Master's

Category
Biology & Biotech (1)
Required Skills
Quality Assurance (QA)
Data Analysis

Get referred to Granules

See people who can refer or advise you

Requirements
  • Expert-level knowledge of FDA guidance for industry, Title 21 of the Code of Federal Regulations, and compendia such as USP, EP, and BP.
  • Knowledge of current Good Manufacturing Practice compliance within the pharmaceutical manufacturing industry.
  • Experience writing and maintaining current Good Manufacturing Practice documentation.
  • Ability to analyze data and information and resolve complex issues.
  • Verbal and written communication skills.
  • Ability to work and communicate with cross-functional teams.
  • Ability to manage multiple priorities and reprioritize tasks.
  • Strong computer skills and working knowledge of Microsoft Office Suite and Adobe.
  • Demonstrated ability to work on complex assignments in collaboration with various departments.
  • A bachelor's degree in the life sciences or equivalent work experience, with at least 6 years of experience in a Quality Assurance role within the pharmaceutical industry.
  • A master's degree with at least 4 years of pharmaceutical manufacturing experience, including at least 3 years in a progressive Quality Assurance department in the pharmaceutical industry.
  • Ability to stand, sit, talk, hear, and use hands and fingers to operate a computer and telephone keyboard.
  • Close vision sufficient for computer work.
  • Ability to sit at a computer terminal for an extended period.
  • Ability to lift 10 to 15 pounds.
  • Ability to work in a confined area.
Responsibilities
  • Manage and ensure that the facility meets all Good Manufacturing Practice, Food and Drug Administration, and standard operating procedure requirements.
  • Manage quality operations, including inspection of components, bulk products, and final products for the Chantilly facility, while ensuring release lead times are met through timely product disposition.
  • Ensure that the facility meets all training requirements.
  • Lead communication of open quality-document notifications and resolutions between departments for complaints, investigations, change controls, corrective and preventive actions, including corrective and preventive action verification, and other quality documents.
  • Manage and maintain internal and external audit inspections for the site.
  • Support the preparation, review, processing, and approval of validation documents for the Granules Chantilly facility.
  • Provide Quality Assurance support, review, and approval for procedures, batch records, specifications, stability reports, technical reports such as qualification, validation, and transportation reports, trend reports, annual product quality reviews, and other documents.
  • Manage the performance and development of Quality Assurance staff through mentoring and focus on personal and professional growth.
  • Work with the Quality leadership team on proactive succession planning and building a high-performance culture through people.
  • Guide and lead staff by setting realistic personal goals and providing regularly scheduled feedback throughout the year.
  • Provide tools, equipment, and methods for new and existing processes to support continuous improvement.
  • Implement Quality management system tools and ensure compliance.
  • Develop and execute quality training modules for the organization.
  • Ensure staff receive appropriate knowledge, skills, development, and growth opportunities.
  • Work with Regulatory Affairs to supply information needed for Food and Drug Administration filings.
  • Perform other duties assigned by management.

Granules India makes APIs, PFIs, and finished dosages, using large-scale, vertically integrated plants that control production from base chemicals to final medicines. Its products include common off-patent APIs like Paracetamol, Ibuprofen, Metformin, and Guaifenesin, and it is expanding into more complex areas such as MUPS, oncology, and peptide therapies with US FDA approvals. The company differentiates itself through full vertical integration, large scale, and a global manufacturing footprint that supports both contract manufacturing and its own branded products, offering supply security and cost competitiveness. Its goal is to deliver reliable, affordable medicines to customers worldwide while growing capabilities in complex therapies and pursuing sustainable practices like green chemistry.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

2014

Get referred to Granules

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q3 FY26 revenue rose 22% to INR 1,388 crores, led by North America and Europe.
  • July 2026 inspections at Genome Valley and Chantilly improved regulatory optionality and capacity.
  • Europe grew 151% year-on-year in FY26, while peptide CDMO opened a new revenue vertical.

What critics are saying

  • FDA warning letter dated February 26, 2025 threatens Gagillapur product approvals until remediation closes.
  • Reuters on April 9, 2026 reported record-keeping and contamination concerns still burden management.
  • Any second FDA action at Gagillapur can shut U.S. launches and damage Granules' generics franchise.

What makes Granules unique

  • Granules integrates APIs, PFIs, and dosages, preserving cost control across the value chain.
  • February 2025 Senn Chemicals acquisition adds peptide CDMO capabilities and European regulated-market access.
  • Granules shipped in 80 countries and won 94 approvals by August 2026.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours